Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Says Preapproval Inspections Will Not Trigger Surveillance Audits

Executive Summary

Decisions to conduct GMP surveillance audits for currently marketed products are not triggered by pending NDAs subject to preapproval inspections, FDA official confirms. The two types of inspections are “delinked” from each other.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register